Zydus gets USFDA final approval for Imatinib Mesylate Tablets Medical Dialogues Bureau9 April 2020 7:31 AM GMTAhmedabad: Zydus Cadila has received final approval from the USFDA to market Imatinib Mesylate Tablets, 100 mg and 400 mg. (US RLD: Gleevec® Tablets)Th...
Zydus gets USFDA final approval for Perphenazine Tablets USP Medical Dialogues Bureau8 April 2020 7:26 AM GMTAhmedabad: Zydus Cadila has received final approval from the USFDA to market Perphenazine Tablets USP, 2 mg, 4 mg, 8 mg and 16 mg. (US RLD: Trilafon® T...
Coronavirus: Zydus Wellness launches hand sanitizer under Nycil brand to meet growing demand Medical Dialogues Bureau2 April 2020 7:30 AM GMTNycil sanitizer consists of neem and aloevera extracts that helps kill 99.9 percent germs, Zydus Wellness said
World's first drug for treatment of Non-Cirrhotic NASH approved: Zydus Medical Dialogues Bureau6 March 2020 8:56 AM GMTSaroglitazar is uniquely poised with its dual PPAR alpha and gamma properties – reducing the comorbidities (dyslipidemia, hypertriglyceridemia,...
Zydus gets DCGI nod for Phase I clinical trial of ZYBK2b to treat Rheumatoid Arthritis Medical Dialogues Bureau4 March 2020 5:04 AM GMTZYBK2 has been specifically designed to inhibit HLA-DRB1 Shared Epitope (SE) that determines the susceptibility of a person to develop rheumatoid...